| Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder (NCT07499583) | Indiana University | 2026-08-01 |
| Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA (NCT06948552) | Henry Ford Health System | 2026-08-01 |
| Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer (NCT07539155) | University of Arkansas | 2026-08-01 |
| Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma (NCT07521657) | University of Alabama at Birmingham | 2026-08-01 |
| A Positron Emission Tomography (PET) Study to Evaluate Dopamine D2 and D3 Receptor Occupancy by SIPI6398 (NCT07626034) | Shanghai Zhongze Therapeutics Co., Ltd. | 2026-08-01 |
| A Single-Arm Study of Sintilimab and Disitamab Vedotin for Locally Advanced Eyelid Sebaceous Gland Carcinoma (NCT07740993) | West China Hospital | 2026-08-01 |
| A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy (NCT07592910) | Prostate Cancer Clinical Trials Consortium | 2026-08-01 |
| Pediatric Asthma Trial of Corticosteroid Heterogeneity (PATCH): Trial of Dexamethasone Versus Methylprednisolone for Pediatric Critical Asthma (NCT07455396) | Johns Hopkins All Children's Hospital | 2026-08-01 |
| A Study of Combination Therapy in Patients With Resectable Liver Cancer (NCT07684040) | Affiliated Hospital of Guangdong Medical University | 2026-08-01 |
| Bevacizumab, Sintilimab, Cetuximab and Irinotecan in Refractory RAS Wild-type Metastatic Colorectal Cancer: BOND-4 Trial (NCT07722754) | Guangdong Provincial People's Hospital | 2026-08-01 |
| Functional Imaging of Digital Osteoarthritis and Rheumatoid Arthritis Using 99mTc-NTP 15-5 in Nuclear Medicine (NCT07624994) | Centre Jean Perrin | 2026-08-01 |
| Bariatric Endoscopic Antral Myotomy Combined With Fundal Gastric Mucosal Ablation (NCT07612527) | Cairo University | 2026-08-01 |
| Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG). (NCT07680439) | BrainChild Bio, Inc | 2026-08-01 |
| Repeated Injections of Adipose-derived Stem Cells in Rotator Cuff Tears (NCT07592936) | University of Southern Denmark | 2026-08-01 |
| Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC) (NCT07433673) | Columbia University | 2026-08-01 |
| A Phase II Study of TollB-001 Tablets in Systemic Sclerosis (NCT07745725) | Toll Biotech Co. Ltd. (Beijing) | 2026-08-01 |
| Efficacy and Safety of Serplulimab in Combination With Bevacizumab and FOLFIRINOX or NALIRIFOX as Second-Line Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (NCT07733050) | Shanghai General Hospital, China | 2026-08-01 |
| ML-016 in Advanced Cancer With Lung and/or Liver Involvement (NCT07723482) | BrYet US, Inc. | 2026-08-01 |
| Laryngeal Vibro-tactile Stimulation as a Non-invasive Symptomatic Treatment for Spasmodic Dysphonia (NCT05467228) | University of Minnesota | 2026-08-01 |
| Effectiveness of Posluma PET Scan for Post-Treatment Monitoring of Prostate Cancer (NCT07733908) | Aditya Bagrodia | 2026-08-01 |
| Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia (NCT07689162) | Washington University School of Medicine | 2026-08-01 |
| A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PTT-621 in Patients With Moderately to Severely Active Ulcerative Colitis (NCT07747155) | Pyrotech Therapeutics, Inc. | 2026-08-01 |
| PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT (NCT07550517) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-08-01 |
| Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis (NCT07646223) | Tampere University Hospital | 2026-08-01 |
| A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer (NCT07766018) | Stemline Therapeutics, Inc. | 2026-08-01 |
| Sonication-based OCD Neurosurgical Intervention Via Capsulotomy (NCT06131502) | Brigham and Women's Hospital | 2026-08-01 |
| Teprotumumab N01 Versus Methylprednisolone After Urgent Orbital Decompression for Dysthyroid Optic Neuropathy (NCT07594912) | Sun Yat-sen University | 2026-08-01 |
| Romiplostim N01 for Injection for Secondary Prophylaxis of CIT in Breast Cancer (NCT07771881) | Fudan University | 2026-08-01 |
| Hyperbaric Oxygen Therapy as Adjunctive Treatment for Fracture-Related Infection (NCT07535164) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2026-08-01 |
| The Effect of Nicorandil on Rheumatoid Arthritis Patients (NCT07730723) | Ain Shams University | 2026-08-01 |
| A Study to Investigate Pharmacokinetics, Safety, and Tolerability of B2227 Extended-Release Injectable Suspension and Vraylar® in Participants With Schizophrenia (NCT07722728) | Bostal Drug Delivery Co., Ltd | 2026-08-01 |
| Safety and Efficacy of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars (NCT07474467) | CellinCells | 2026-08-01 |
| Bicycle Continued Access Protocol (BiCAP) for Participants Receiving a Bicycle Investigational Product (NCT07681674) | BicycleTx Limited | 2026-08-01 |
| Targeting Aurora A Kinase to Overcome Treatment Resistance in Advanced HR+/HER2+ Breast Cancer (NCT07706179) | University of Wisconsin, Madison | 2026-08-01 |
| TEPH: Telaglenastat Efficacy in Pulmonary Hypertension (NCT07223528) | Chan, Stephen, MD, PhD | 2026-08-01 |
| A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT07759245) | Eli Lilly and Company | 2026-08-01 |
| Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis (NCT07524634) | Case Comprehensive Cancer Center | 2026-08-01 |
| Evaluation of NWRD09 for HPV-16 Related Cervical HSIL (NCT07712692) | Newish Biotech (Wuxi) Co., Ltd. | 2026-08-01 |
| Zolbetuximab With mFOLFOX6 or CAPOX in Claudin 18.2 Overexpressed Advanced or Metastatic Biliary Tract Cancers (NCT07723534) | Midhun Malla | 2026-08-01 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Brexpiprazole for Extended-Release Injection in Subjects With Schizophrenia (NCT07742280) | Bostal Drug Delivery Co., Ltd | 2026-08-01 |
| A Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous Ocrelizumab Administration in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS) (NCT07503340) | Hoffmann-La Roche | 2026-08-01 |
| Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepatic Cholangiocarcinoma (NCT07766187) | University of Wisconsin, Madison | 2026-08-01 |
| Culmerciclib in HR+/HER2+ Advanced Breast Cancer (NCT07732491) | Sun Yat-sen University | 2026-08-01 |
| The Gut - PRO Study (NCT07413744) | University of Wisconsin, Madison | 2026-08-01 |
| Neoadjuvant Chemoradiotherapy Combined With CTLA-4 Monoclonal Antibody Plus PD-1 Monoclonal Antibody for Locally Advanced Esophageal Cancer (NCT07751055) | Sun Yat-sen University | 2026-08-01 |
| Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC (NCT07718243) | Institute of Cancer Research, United Kingdom | 2026-08-01 |
| Restoring Vascular and Insulin Function To Augment Anti-Amyloid Therapy in Alzheimer's Disease (NCT07756294) | Wake Forest University Health Sciences | 2026-08-01 |
| Butyrate Yogurt for Cancer Constipation (NCT07723729) | Tianjin Medical University Cancer Institute and Hospital | 2026-08-01 |
| The Effect of Inhalation Aromatherapy on Intraoperative Fear in Patients Undergoing Lower Blepharoplasty Under Local Anesthesia: A Randomized Controlled Trial (NCT07766902) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2026-08-01 |
| Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors (NCT07551778) | BOE Technology Group Co., Ltd. | 2026-08-01 |
| PDT vs Peels for Treatment of Actinic Keratoses (NCT04429308) | Northwestern University | 2026-08-01 |
| Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures (NCT04085887) | Stanford University | 2026-08-01 |
| Preventive Dendritic Cell Vaccination for Lynch Syndrome (NCT07412197) | Radboud University Medical Center | 2026-08-01 |
| A Prospective Study of Response-adapted Low-dose Radiotherapy Combined With Orelabrutinib for Localized Mucosa-associated Lymphoid Tissue Extranodal Marginal Zone Lymphoma (NCT07705308) | Ruijin Hospital | 2026-08-01 |
| TACE Combined With Thermal Ablation and ADC, PD-1, and Chemotherapy as First-line Treatment for HER2-highly-expressing Gastric Cancer With Liver Metastases: A Multicenter, Single-arm Prospective Clinical Study. (NCT07602140) | Shandong Provincial Hospital | 2026-08-01 |
| T Cell Inflamed Gene Expression Profiling Score-guided Anti PD-1 Therapy (Tislelizumab Monotherapy) for Refractory Solid Cancer Patients Unexposed to Immunotherapy (NCT07300891) | Samsung Medical Center | 2026-08-01 |
| SHR-1701 Plus Apatinib for Second-Line Treatment in Targeted-Immune Pretreated Advanced Hepatocellular Carcinoma (NCT07749859) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-08-01 |
| NMDA Enhancement Combined With Omega-3 for Early Dementia (NCT05181189) | Chang Gung Memorial Hospital | 2026-08-01 |
| A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors (NCT07767474) | Antares Therapeutics, Inc | 2026-08-01 |
| dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy (NCT07564102) | Mochida Medical USA, Inc. | 2026-08-01 |
| Mycophenolate After Stem Cell Transplant for Systemic Sclerosis (NCT07734012) | Ottawa Hospital Research Institute | 2026-08-01 |
| Second Trimester Abortion With Letrozole and Misoprostol Compared to Misoprostol Alone (NCT07767435) | Sohag University | 2026-08-01 |
| Toripalimab Combined With Beat Chemotherapy in the Treatment of Advanced Back-line Small Cell Lung Cancer (NCT07698054) | Henan Cancer Hospital | 2026-08-01 |
| AK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine Cancer (NCT07712094) | Tianjin Medical University Cancer Institute and Hospital | 2026-08-01 |
| Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT) (NCT07224009) | University of Arkansas | 2026-08-01 |
| Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Evaluate the Safety and Efficacy of Endosomal Escape Vehicle Phosphorodiamidate Morpholino Oligomer Platform Products (ELEVATE-LTE) (NCT07682129) | Entrada Therapeutics, Inc. | 2026-08-01 |
| Ipilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial (NCT07715565) | West China Hospital | 2026-08-01 |
| Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma (NCT06902246) | University of Miami | 2026-08-01 |
| Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE) (NCT06084780) | Case Comprehensive Cancer Center | 2026-08-01 |
| Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD (NCT07694986) | H. Lee Moffitt Cancer Center and Research Institute | 2026-08-01 |
| Pirfenidone as Treatment of Chronic Pancreatitis (NCT07755813) | Vikas Dudeja | 2026-08-01 |
| Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis (NCT07719530) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-08-01 |
| A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients (NCT06907485) | Costas Hadjipanayis | 2026-08-01 |
| A Phase 2 Trial of 61Cu-NU101 PET/CT Compared Against Current Standard-of-care 18F-piflufolastat (Pylarify®) PET/CT. (NCT07635524) | Hoag Memorial Hospital Presbyterian | 2026-08-01 |
| A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults (NCT07143448) | 35Pharma Inc | 2026-08-01 |
| A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant (NCT07572929) | Medical College of Wisconsin | 2026-08-01 |
| Comparison of Intralesional Glucantime With and Without Fractional CO₂ Laser in Adults With Cutaneous Leishmaniasis (NCT07652021) | Combined military hospital Peshawar | 2026-08-01 |
| Anti-PD-1 Therapy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma (NCT07751289) | Yanjie Zhang, MD | 2026-08-01 |
| Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO) (NCT07573436) | University of Utah | 2026-08-01 |
| Utilize Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin (NCT07682454) | University of California, San Francisco | 2026-08-01 |
| PSMA PET/CT-Guided SBRT Plus Darolutamide in mHSPC (NCT07649421) | West China Hospital | 2026-08-01 |
| Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease (NCT07686770) | Children's Hospital of Fudan University | 2026-08-01 |
| Iparomlimab and Tuvonralimab (QL1706) Plus Lenvatinib and Chemotherapy for Extrapulmonary Neuroendocrine Carcinoma (NCT07738159) | West China Hospital | 2026-08-01 |
| The Efficacy of a Pharmacological Treatment (Reboxetine Plus Ritalin) Versus Dog-Assisted Therapy in PTSD (NCT07771530) | University of Haifa | 2026-08-01 |
| Isa-VRdlite for of Frail and/or Much Older Patients With High Risk Newly Diagnosed Multiple Myeloma Base on Circulating Plasma Cells (NCT07732712) | The Affiliated People's Hospital of Ningbo University | 2026-08-01 |
| Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC (NCT07698106) | University Health Network, Toronto | 2026-08-01 |
| A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies (NCT07735533) | Umoja Biopharma | 2026-08-01 |
| Effects of Curcumin-Piperine Supplementation in Fibromyalgia (NCT07753018) | Ain Shams University | 2026-08-01 |
| Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis (NCT07281924) | University of Wisconsin, Madison | 2026-08-01 |
| UI-Romi-02; Romiplostim Added to Standard of Care for Treatment Naive and Relapsed or Refractory Severe Aplastic Anemia (NCT07001254) | Anjali Sharathkumar | 2026-08-01 |
| Safety and Efficacy of Mutation-targeted Precision Genetic Therapy for Ataxia-Telangiectasia (A-T) (NCT07215416) | Timothy Yu | 2026-08-01 |
| A Clinical Study on the Safety and Efficacy of Wide-Band Ultrasound Combined With Traditional Chinese Medicine Preparations in the Prevention and Treatment of Keloids (NCT07679243) | Fujian Medical University Union Hospital | 2026-08-01 |
| Study of [11C]CPPC as a Clinical PET Radioligand Biomarker of Microglial Activation in ALS (NCT05602142) | Johns Hopkins University | 2026-08-01 |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of TML-6 in Participants With Early Alzheimer's Disease (NCT07612150) | Merry Life Biomedical Co., Ltd. | 2026-08-01 |
| The Impact of Cobenfy Maintenance on Cocaine's Effects (NCT07624227) | Joshua A. Lile, Ph.D. | 2026-08-01 |
| OVV-01 Injection Combined With AK112 Injection for the Treatment of Patients With Advanced Soft Tissue Sarcoma (STS) (NCT07650838) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-08-01 |
| Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases. (NCT07594431) | Stanford University | 2026-08-01 |
| Study of YOLT-203 in Children and Adults With Primary Hyperoxaluria Type 1 (PH1) (NCT07587021) | YolTech Therapeutics Co., Ltd | 2026-08-01 |
| An Open-label, Single Center Study Evaluating the Safety and Efficacy of Roflumilast Foam 0.3% in Subjects With Cutaneous Adverse Events Due to Checkpoint Inhibitors (NCT07639840) | Massachusetts General Hospital | 2026-08-01 |
| A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL Amyloidosis (NCT07765524) | Shenzhen Fosun Kairos Biotechnology Co., Ltd. | 2026-08-01 |